Susanne Antonie Schaffert

Susanne Antonie Schaffert

Susanne Antonie Schaffert

Overview
Career Highlights

Advanced Accelerator Applications SA
Novartis Oncology, Inc.

RelSci Relationships

857

Number of Boards

4

Birthday

1967

Age

53

Contact Data
Trying to get in touch with Susanne Antonie Schaffert? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Susanne Antonie Schaffert likely has professional access to. A relationship does not necessarily indicate a personal connection.

Head of Strategic Venture Capital Fund, Pharma Equities at Novartis AG

Relationship likelihood: Strong

Chairman & President at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Medical Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Novartis AG

Relationship likelihood: Strong

Chief Financial Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

Chief Operations Officer at Advanced Accelerator Applications SA

Relationship likelihood: Strong

President of Novartis Pharmaceuticals at Novartis AG

Relationship likelihood: Strong

Director at Abeona Therapeutics LLC

Relationship likelihood: Strong

Chief Executive Officer at Novartis AG

Relationship likelihood: Strong

Group General Counsel of Novartis at Novartis AG

Relationship likelihood: Strong

Paths to Susanne Antonie Schaffert
Potential Connections via
Relationship Science
You
Susanne Antonie Schaffert
Career History
President of Novartis Oncology
Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Chairman & President
2018 - 2019

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. It offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. The company manufactures both diagnostic and therapeutic MNM products for commercialization. Advanced Accelerator Applications was founded in 2002 by Stefano Buono and is headquartered in Saint Genis Pouilly, France.

Chief Executive Officer
2019 - Current

Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ.

Boards & Committees
Member, Executive Committee
2019 - Current

Novartis AG is a holding company, which engages in the development, manufacture, and marketing of healthcare products. It operates through the following segments: Innovative Medicines, Sandoz, and Corporate. The Innovative Medicines segment researches, develops, manufactures, distributes and sells patented pharmaceuticals, and is composed of two business units: Novartis Oncology and Novartis Pharmaceuticals. The Sandoz segment develops, manufactures and markets finished dosage form medicines as well as intermediary products including active pharmaceutical ingredients. The Corporate segment refers to group management and central services. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.

Member-Supervisory Board
Current

CIBA Vision GmbH (Germany), a subsidiary of Novartis AG, is a company headquartered in Grosswallstadt, Germany, that manufactures and markets contact lenses. It was founded in 1983. Norbert Dörr is currently the CEO of the firm.The company says this about itself: CIBA VISION GmbH in Grosswallstadt produces one-day contact lenses for the brand DAILIES®. More than 1,000 employees work in the areas of production, research and development and logistics. CIBA VISION® and Alcon® bundle their skills since April 2012 and were introduced to market as the new business unit Alcon Vision Care of the Novartis Group. The company operates in 75 countries and sells products in 180 markets.

Chairman & President
2018 - 2019

Advanced Accelerator Applications SA is a radiopharmaceutical company, which develops, produces and commercializes molecular nuclear medicine products. The firm offers research and development in medicinal and pharmaceutical therapeutic products mainly focusing in cardiology and neurology. It manufactures both diagnostic and therapeutic MNM products for commercialization. The company was founded by Stefano Buono in 2002 and is headquartered in Saint Genis Pouilly, France.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Susanne Antonie Schaffert. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Susanne Antonie Schaffert's profile does not indicate a business or promotional relationship of any kind between RelSci and Susanne Antonie Schaffert.